Skip to main content

Table 4 Comparison of side effects of therapies between groups

From: The effect of anti-cancer and anti-tuberculosis treatments in lung cancer patients with active tuberculosis: a retrospective analysis

variable TB treatment
n (%)
Lung cancer
n (%)
P value
Leukocyte deficiency    0.887
 Nothing 13 (41.9) 26 (51.0)  
 Grade 1 7 (22.6) 10 (19.6)  
 Grade 2 8 (25.8) 11 (21.6)  
 Grade 3 3 (9.7) 4 (7.8)  
Thrombocytopenia    0.508
 Nothing 19 (61.3) 37 (72.5)  
 Grade 1 6 (19.4) 5 (9.8)  
 Grade 2 4 (12.9) 5 (9.8)  
 Grade 3 2 (6.5) 2 (3.9)  
 Grade 4 0 (0) 2 (3.9)  
Renal toxic effects    0.236
 Nothing 15 (48.4) 27 (52.9)  
 Grade 1 14 (45.2) 24 (47.1)  
 Grade 2 2 (6.5) 0 (0)  
Liver toxicity    0.173
 Nothing 12 (38.7) 24 (47.1)  
 Grade 1 12 (38.7) 23 (45.1)  
 Grade 2 5 (16.1) 4 (7.8)  
 Grade 3 2 (6.5) 0 (0)  
Gastrointestinal toxicity    0.067
 Nothing 15 (48.4) 32 (62.8)  
 Grade 1 9 (29.0) 13 (25.5)  
 Grade 2 7 (22.6) 5 (9.8)  
 Grade 3 0 (0) 1 (2.0)  
Cardiac toxic effects 6 (19.4) 7 (13.7) 0.499
Neurotoxicity 0 (0) 0 (0) 1